💨 Abstract

Aquestive Therapeutics Inc. (AQST) reported a first-quarter loss of $22.9 million, or 24 cents per share, missing Wall Street's expectations of a 17 cents per share loss. The company's revenue of $8.7 million also fell short of the projected $12.1 million. Shares were trading at $2.87, down from $3.09 a year ago.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖